Technology
Health
Medical

Biolase

$2.39
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.03 (-1.24%) Today
-$0.03 (-1.24%) Today

Why Robinhood?

You can buy or sell Biolase and other stocks, options, ETFs, and crypto commission-free!

About

Biolase, Inc. Common Stock, also called Biolase, is a medical device company, which engages in the development, manufacture, market and sale of laser systems in dentistry and medicine. Read More It operates through Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems uses a patented combination of water and laser energy to perform procedures using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. The Diode systems performs soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. The company was founded in 1987 and is headquartered in Irvine, CA.

Employees
190
Headquarters
Irvine, California
Founded
1987
Market Cap
51.00M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
65.06K
High Today
$2.40
Low Today
$2.38
Open Price
$2.40
Volume
14.79K
52 Week High
$2.98
52 Week Low
$0.91

Collections

Technology
Health
Medical
Software Service
US
North America

News

Guru FocusMar 8

Biolase Inc (BIOL) Files 10-K for the Fiscal Year Ended on December 31, 2018

Biolase Inc (NASDAQ:BIOL) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Biolase Inc is a medical device company that develops, manufactures, and markets lasers in dentistry and medicine and also markets and distributes dental imaging equipment.

54
Seeking AlphaMar 5

BIOLASE, Inc. (BIOL) CEO Todd Norbe on Q4 2018 Results - Earnings Call Transcript

BIOLASE, Inc. (NASDAQ:BIOL) Q4 2018 Earnings Conference Call March 5, 2019 4:30 PM ET Company Participants Todd Kehrli - Investor Relations, EVC Group Todd Norbe - President & Chief Executive Officer John Beaver - Executive Vice President & Chief Financial Officer Conference Call Participants Ed Woo - Ascendiant Capital Lisa Springer - Singular Research Brooks O’Neil - Lake Street Capital Markets Operator Good afternoon, ladies and gentlemen, and welcome to the Fourth Quarter and Full Year 2018 BI...

33
Yahoo FinanceMar 5

BIOLASE Reports 2018 Fourth Quarter and Full Year Results

- Fourth Quarter U.S. Laser Revenue Increased 51% Year Over Year - - Fourth Quarter U.S. Consumables and Other Revenue Increased 13% Year Over Year - - 2018 Gross Margin Increased by nearly 1,500 Basis Points Year Over Year - - Conference Call Today at 4:30pm ET / 1:30pm PT - IRVINE, Calif., March 5, 2019 /PRNewswire/ -- BIOLASE, Inc. (BIOL), the global leader in dental lasers, today reported net revenue of $13.0 million and $46.2 million for the fourth quarter and year ended December 31, 2018, respecti...

17

Earnings

-$0.20
-$0.14
-$0.09
-$0.03
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 1, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.